Unlock instant, AI-driven research and patent intelligence for your innovation.

Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same

a technology of glucose homeostasis and nucleic acid sequences, applied in the field of nucleic acid sequences coding for sugar transporters, can solve the problems of linkage disequilibrium, hyperglycemic systemic condition, traditional genetic approaches have proven inadequate to achieve this goal, etc., and achieve the effect of facilitating diagnosis

Inactive Publication Date: 2009-02-26
CHEN Y T +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a novel glucose transporter polypeptide and a polynucleotide encoding it. The polypeptide is involved in the transport of glucose in the body and is associated with disorders affecting glucose homeostasis. The invention also provides methods for detecting variations in the glucose transporter polypeptide in a biological sample, which can be used for diagnosis and screening purposes. The invention also includes therapeutic methods for modulating glucose transport using the novel polynucleotide and polypeptide. The technical effects of the invention include improved diagnosis and treatment of glucose homeostasis disorders.

Problems solved by technology

Diabetes mellitus is a condition in which the glucose homeostasis of a subject becomes unbalanced and leads to a hyperglycemic systemic condition.
Traditional genetic approaches have proven to be inadequate to accomplish this goal.
Linkage disequilibrium analysis, for example, which has historically proven helpful in studying complex disease genes, has not yet yielded results useful for Type II diabetes-related therapeutic treatments.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
  • Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
  • Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

Laboratory Example 1

Search of the EST Databases

[0280]The NCBI and TIGR expressed sequence tag (EST) databases were searched for novel isoforms of sugar transport proteins, using the polypeptide sequence of known sugar transporters, GLUTs 1-5. A BLAST-type search was performed, based on protein sequence motifs known to be present in the GLUT family of proteins. The search criteria included either the entire polypeptide sequence or keywords such as “sugar transporter”. Candidate glucose transporter sequences were identified (e.g. a 306 base pair (bp) EST named EST183920 with locus and accession number AA313045) in the search and used in the generation of the full-length cDNA.

example 2

Laboratory Example 2

Generation of the Full-Length cDNA and Chromosomal Localization

[0281]The 5′ and 3′ cDNA sequences were obtained using 5′ and 3′ rapid amplification of cDNA ends (RACE). The full-length cDNA was then amplified by long range PCR from normal human liver cDNA using the high fidelity Expand™ enzyme (Boehringer Mannheim, Mannheim, Germany).

[0282]The chromosomal localization and gene structure were determined by the identification of a BAC clone containing the genomic DNA sequence of the novel GLUT. The BAC clone was identified from the databases and had Locus number HS28H20 and accession number AL031055. It was 127,418 bp in length and had been localized to chromosome 20q13.1.

example 3

Laboratory Example 3

Tissue Distribution of the Novel Polynucleotide Sequence

[0283]FIG. 4 is an autoradiograph of a Northern blot showing the tissue distribution of the novel polynucleotide sequence. Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas tissue were probed for the presence of the novel sequence. Of the tissues probed, the sequence is most pronounced in liver and pancreas tissue.

[0284]Conditions for the Northern blot were as follows. The probe was a PCR product corresponding to residues 1394-1636 of SEQ ID NO: 1. The probe was labeled with 32P by the random priming method.

[0285]The Northern blot was bought commercially from Clontech of Palo Alto, Calif. Probe conditions were 68° C. hybridization for 1 hr using a hybridization buffer sold under the trademark EXPRESSHYB™ by Clontech of Palo Alto, Calif., followed by 2 washes with 2×SSC, 0.05% SDS for 40 minutes, each at room temperature.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

An isolated and substantially pure nucleic acid sequence located between D20S119 and D20S178 on human chromosome 20q13, the nucleic acid sequence including: a nucleic acid sequence coding for a glucose transporting protein and having the sequence shown in SEQ ID NO: 1; or a nucleic acid sequence having at least 70% sequence identity with the nucleic acid sequence shown in SEQ ID NO: 1. The disclosed nucleic acid sequences map to a locus associated with human Type II diabetes mellitus and, therefore, therapeutic and diagnostic screening methods, which accommodate naturally and artificially occurring polymorphisms, are also disclosed.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is based on and claims priority to U.S. Provisional Application Ser. No. 60 / 215,477, filed Jun. 29, 2000, herein incorporated by reference in its entirety.TECHNICAL FIELD[0002]The present invention relates generally to nucleic acid sequences coding for sugar transporters useful for screening against glucose homeostasis disorders, and particularly to nucleic acid sequences coding for the glucose transporter which map to the region between D20S119 and D20S178 on human chromosome 20q13.BACKGROUND ART[0003]The publications and other materials used herein to illuminate the background of the invention, and in particular cases, to provide additional details respecting the practice, are incorporated herein by reference, and for convenience, are referenced by author and date in the text.[0004]Diabetes mellitus is a condition in which the glucose homeostasis of a subject becomes unbalanced and leads to a hyperglycemic systemic cond...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68C07K14/62G01N33/564
CPCC07K14/62C12Q1/6883G01N2800/042G01N33/564G01N2500/00C12Q2600/156
Inventor CHEN, Y. T.MCVIE-WYLIE, ALISON J.
Owner CHEN Y T